Licenses Clear Path For Daclatasvir In Asia/Africa HCV/HIV Program
This article was originally published in PharmAsia News
Executive Summary
The first supplies of daclatasvir for use in a new US-coordinated program aimed at improving drug access for patients co-infected with HIV/HCV in Asian and African countries will reach first recipients shortly.